Effect of solubilized membrane antigens and tumour bearer serum on tumour growth in syngeneic hosts.
D000230:Adenocarcinoma / Q000276:immunology / Q000628:therapy; D000818:Animals; D000951:Antigens, Neoplasm / Q000008:administration & dosage; D001769:Blood; D002462:Cell Membrane / Q000276:immunology; D007114:Immunization; D007167:Immunotherapy; D007279:Injections, Subcutaneous; D008297:Male; D051379:Mice; D008807:Mice, Inbred BALB C; D008854:Microscopy, Electron; D009368:Neoplasm Transplantation; D009374:Neoplasms, Experimental / Q000276:immunology* / Q000628:therapy; D010954:Plasmacytoma / Q000276:immunology / Q000628:therapy
D000951:Antigens, Neoplasm